Valiant Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 26	Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22

Sales

217.04

133.36

182.05

333.91

291.52

Operating profit

7.18

-4.68

-8.41

35.09

42.32

Interest

0.26

0.18

0.08

0.25

0.07

Gross profit

9.81

0.58

1.20

39.70

44.19

EPS (Rs)

1.02

-0.49

0.08

8.91

16.89

Other income

2.89

5.43

9.68

4.86

1.95

Stock adjustment

0.21

3.86

-1.14

-0.24

-1.97

Raw material

171.53

112.16

169.39

277.28

236.43

Power and fuel

-

-

-

-

-

Employee expenses

5.00

4.39

4.31

4.61

3.06

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

33.12

17.63

17.90

17.17

11.69

Provisions made

-

-

-

-

-

Depreciation

2.26

2.02

1.95

1.56

2.49

Taxation

2.00

0.70

-1.09

9.14

14.21

Net profit / loss

5.55

-2.15

0.34

29.00

27.50

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

54.31

43.45

43.45

32.56

16.28

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

3.31

-3.51

-4.62

10.51

14.52

GPM (%)

4.46

.42

.62

11.72

15.06

NPM (%)

2.52

-1.55

0.18

8.56

9.37